Elevra Lithium Ltd (ELVR) - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K covers the Quarterly Activities Report for the period ended June 30, 2026, filed on July 28, 2026. Elevra Lithium Limited is North America's largest hard-rock lithium producer, operating the North American Lithium (NAL) mine in Quebec, Canada, and advancing growth projects including the Moblan and Carolina Lithium projects.
Key Financial Metrics
| Metric | Q4 FY26 (June 2026) | Q3 FY26 (March 2026) | QoQ Variance |
|---|---|---|---|
| Revenue (US$M) | 31 | 81 | (61%) |
| Spodumene Sold (dmt) | 33,977 | 55,526 | (39%) |
| Avg. Realised Price (US$/dmt) | 921 | 1,453 | (37%) |
| Unit Operating Cost (US$/dmt) | 907 | 884 | 3% |
| Cash Balance (US$M) | 255 | 113 | 126% |
| Net Cash (US$M) | 200 | 59 | 239% |
| Operating Profit (NAL) (US$M) | 1 | N/A | N/A |
| Capital Expenditure (US$M) | 4 | N/A | N/A |
Note: NAL reported a net operating cash outflow of US$50 million for the quarter due to working capital movements.
Material Changes vs. Prior Period
- Revenue Decline: Revenue dropped 61% QoQ due to a 39% decrease in tonnes sold and a 37% decrease in realised price. This was driven by the finalisation of a legacy multi-year contract with a lagged pricing mechanism that did not reflect recent spot price increases.
- Production Records: Despite lower sales, concentrate production increased 15% QoQ to 54,479 dmt, marking the second-best quarterly performance on record. A new monthly production record of 22,202 dmt was set in May 2026.
- Operational Efficiency: Lithium recoveries improved by 5% QoQ to 71%, supported by high mill utilisation (92%) and improved feed grades.
- Liquidity Surge: Cash balances increased significantly to US$255 million (Net Cash US$200 million) following a strategic financing package and prior to the receipt of proceeds from the Ewoyaa Project sale.
Guidance, Outlook, and Management Commentary
- Strategic Financing: The Company secured a US$298 million package (US$196M equity placement + US$102M Convertible Notes from Canada Growth Fund) to fully fund the NAL Brownfield Expansion. The Upfront Tranche of US$46M was approved by shareholders in July 2026.
- Expansion Milestone: Groundbreaking occurred for the fully funded NAL Expansion. An updated scoping study indicates the project will double incremental post-tax NPV to C$969 million while maintaining total capex at C$366 million.
- Portfolio Rationalisation: Elevra agreed to sell its interest in the Ewoyaa Project (Ghana) to Huayou for approximately US$71 million cash, expected to complete in Q3 CY26. This removes future funding obligations and simplifies the portfolio.
- Pricing Outlook: Management expects future pricing (Q1 FY27 onwards) to align more closely with spodumene spot prices now that the legacy contract is concluded.
- Guidance: Full year FY26 results and FY27 guidance are expected in late August 2026.
Investor Verification Checklist
- Legacy Contract Exit: Verify the exact timing of the first shipment under new spot-based pricing to confirm revenue recovery in Q1 FY27.
- Financing Tranches: Monitor the conditions for the second tranche of the Canada Growth Fund Convertible Notes (US$56M) and shareholder approval status.
- Ewoyaa Sale Completion: Confirm the closing date and final net proceeds of the US$71 million Ewoyaa divestment in Q3 CY26.
- Expansion Capex: Track capital expenditure against the C$366 million budget for the NAL Expansion to ensure cost discipline.
- Working Capital: Review the impact of inventory build-up (US$18M increase) and receivables on future cash flow statements.